These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 6631718

  • 1. Stereoselective increase in propranolol bioavailability during chronic dosing in the dog.
    Bai SA, Wilson MJ, Walle UK, Walle T.
    J Pharmacol Exp Ther; 1983 Nov; 227(2):360-4. PubMed ID: 6631718
    [Abstract] [Full Text] [Related]

  • 2. Stereochemical composition of propranolol metabolites in the dog using stable isotope-labeled pseudoracemates.
    Walle T, Wilson MJ, Walle UK, Bai SA.
    Drug Metab Dispos; 1983 Nov; 11(6):544-9. PubMed ID: 6140137
    [Abstract] [Full Text] [Related]

  • 3. Stereoselective oral bioavailability of (+/-)-propranolol in the dog. A GC-MS study using a stable isotope technique.
    Walle T, Walle UK.
    Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):453-64. PubMed ID: 461970
    [Abstract] [Full Text] [Related]

  • 4. Stereoselective disposition of propranolol in rabbits. Role of presystemic organs and dose.
    Marier JF, Pichette V, du Souich P.
    Drug Metab Dispos; 1998 Feb; 26(2):164-9. PubMed ID: 9456303
    [Abstract] [Full Text] [Related]

  • 5. Stereoselective ring oxidation of propranolol in man.
    Walle T, Walle UK, Wilson MJ, Fagan TC, Gaffney TE.
    Br J Clin Pharmacol; 1984 Nov; 18(5):741-8. PubMed ID: 6508983
    [Abstract] [Full Text] [Related]

  • 6. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
    Vu VT, Bai SA, Abramson FP.
    J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
    [Abstract] [Full Text] [Related]

  • 7. Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
    Lankford SM, Maskasame C, Bai SA.
    Drug Metab Dispos; 1994 Jan; 22(5):776-87. PubMed ID: 7835231
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Stereochemistry of the in vivo disposition and metabolism of propranolol in dog and man using deuterium-labeled pseudoracemates.
    Walle T.
    Drug Metab Dispos; 1985 Jan; 13(3):279-82. PubMed ID: 2861983
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Partial metabolic clearances as determinants of the oral bioavailability of propranolol.
    Walle T, Walle UK, Olanoff LS, Conradi EC.
    Br J Clin Pharmacol; 1986 Sep; 22(3):317-23. PubMed ID: 3768243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.